It is a pharma private limited company based in Mahesana, Gujarat, India, established in 2023.
2023 | Mahesana, Gujarat, India | ActiveNeovant Therapeutics Private Limited, a active private limited company, was established on 23 February 2023 in Mahesana, Gujarat, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U21002GJ2023PTC138826. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.15 M.
Its leadership includes Ramakrishna Guduru (Director), Jagdish Madhavlal Chaudhary (Director), Umesh Vinayakrao Barabde (Director). Past directors included Umesh Vinayakrao Barabde, Vishakh Ramrao Kharat, Rakeshkumar Keshavlal Chaudhary. It holds ₹1.95 Cr open charges and no settled loans. Its latest AGM occurred on 31 December 2024, with the balance sheet filed on 31 March 2024. It is based at Keshav Holiday Resort Private Limited, Amipura, Ahmedabad-Mahesana Highway, Linch, Mahesana, Gujarat, 384435.
U21002GJ2023PTC138826
138826
23 February 2023
₹0.50 M
₹0.15 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Neovant Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramakrishna Guduru | Director | 10 Mar 2023 | Current |
| Jagdish Madhavlal Chaudhary | Director | 23 Feb 2023 | Current |
| Umesh Vinayakrao Barabde | Director | 01 Dec 2023 | Current |
| Vishakh Ramrao Kharat | Director | 01 Dec 2023 | Current |
| Nirav Pravinkumar Trivedi | Director | 10 Mar 2023 | Current |
| Dashrathbhai Kalidas Patel | Director | 10 Mar 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Dec 2024 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2024 | Past |
| Pramod Abcsdd | Non- Individual Subscriber | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Neovant Therapeutics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Neovant Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹19,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Dec 2023 | State Bank Of India | ₹1.95 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Neovant Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Neovant Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neovant Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Neovant Therapeutics Private Limited last Annual general meeting of members was held on 31 Dec 2024 as per latest MCA records. was recorded as a recent event.
The activity Neovant Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.
Progress on A charge with State Bank Of India amounted to Rs. 19.50 M with Charge ID 100849526 was registered on 26 Dec 2023. was documented.
Progress on Umesh Vinayakrao Barabde was appointed as a Director was appointed as a Director on 01 Dec 2023 & has been associated with this company since 2 years 3 days . was documented.
Vishakh Ramrao Kharat was appointed as a Director was appointed as a Director on 01 Dec 2023 & has been associated with this company since 2 years 3 days . was recorded as a recent event.
Ramakrishna Guduru was appointed as a Director was appointed as a Director on 10 Mar 2023 & has been associated with this company since 2 years 8 months . was recorded as a recent event.
The CIN of Neovant Therapeutics Private Limited is U21002GJ2023PTC138826.
Neovant Therapeutics Private Limited is headquartered at Keshav Holiday Resort Private Limited, Amipura, Ahmedabad-Mahesana Highway, Linch, Mahesana, Gujarat, 384435.
Neovant Therapeutics Private Limited was incorporated on 23 February 2023.
The current directors of Neovant Therapeutics Private Limited are
The primary industry of Neovant Therapeutics Private Limited is Pharma.
Neovant Therapeutics Private Limited is unlisted.
The authorized capital of Neovant Therapeutics Private Limited is ₹0.50 M, and the paid-up capital is ₹0.15 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX